International Flavors & Fragrances Inc. (NYSE:IFF) Sets Up Near-Term Rebound On Undervalued Valuation

International Flavors & Fragrances Inc. shows valuation support for a near-term recovery while technical momentum signals a mixed but increasingly bullish tilt. Fundamentals display improving margins and cash generation alongside leverage that warrants monitoring.

Recent News

On July 9, 2025 IFF announced the timing of its second-quarter 2025 results and investor webcast to follow the August 5 close. On July 30, 2025 the board declared a $0.40 quarterly cash dividend payable October 10, 2025. The company’s August 5, 2025 second-quarter release reiterated full-year 2025 guidance, outlined a planned divestiture of its soy crush, concentrates & lecithin business to Bunge expected to close by year-end 2025, and described capital allocation priorities including repurchases funded from cash and operating cash flow.

Technical Analysis

ADX at 26.08 indicates emerging trend strength, lending weight to recent directional signals without implying trend exhaustion.

DI+ shows a decreasing trend while DI- shows a peak & reversal; the DI- peak & reversal implies a bullish directional tilt even as DI+ falls, signaling sellers lost momentum relative to buyers.

MACD registers -1.61 with a dip & reversal trend and the MACD line sitting slightly below its signal at -1.49; the dip & reversal suggests bullish momentum building even though the MACD remains negative and below the signal line.

MRO stands at -31.17 with a dip & reversal trend; the negative MRO indicates price sits below the model target and therefore implies upward potential toward fair-value levels implied by the valuation.

RSI at 38.08 and decreasing describes short-term bearish pressure but remains above extreme oversold levels, leaving room for a momentum-driven bounce if buying interest resumes.

Price sits at $60.96, below the 20-day average ($62.62), the 50-day average ($66.45) and the 200-day average ($75.59); Bollinger lower band near $60.81 places the current price just above the 1x lower band, consistent with stabilization risk-reward near recent lows. Ichimoku cloud values (Senkou A $69.29, Senkou B $70.94) keep price beneath the cloud, maintaining a broader bearish context that short-term momentum can nonetheless challenge.

 


Fundamental Analysis

Revenue totaled $2,764,000,000 with year-over-year revenue growth of 7.06% and quarter-over-quarter revenue change of -2.07%, indicating healthy annual expansion offset by some near-term sequential softness.

Operating margin stands at 7.96% while EBIT margin measures 21.53%; EBIT margin improved 1.37% year-over-year but contracted -1.66% quarter-over-quarter, showing stronger underlying profitability on an annual basis despite recent compression.

EPS came in at $1.15 versus an estimate of $1.12, producing an EPS surprise of 2.68%, while forward EPS sits at $1.1525 and forward P/E at 66.28. Trailing P/E reads 65.56, reflecting elevated multiple relative to absolute earnings but consistent with modest forward growth expectations and sector dynamics.

Capital structure shows total debt of $6,850,000,000 and net debt of $5,368,000,000 with debt to EBITDA of 8.18; interest coverage equals 9.75x. Debt-to-EBITDA suggests material leverage, whereas coverage reflects an adequate ability to service interest expense given current operating earnings.

Cash generation shows operating cash flow of $241,000,000 and free cash flow of $146,000,000, with a free cash flow yield near 0.80% and cash on hand of $816,000,000. The cash conversion cycle of 114.15 days exceeds the peer mean of 91.22 days, indicating working capital turns lag some peers and tying up capital in the short term.

Return measures: return on assets 2.25% and return on equity 4.25% with duPont ROE around 4.44%, consistent with modest capital efficiency while intangible assets weigh on tangible equity (net tangible assets negative $309,000,000).

Valuation context: WMDST values the stock as under-valued based on enterprise and equity metrics, supported by lower price-to-book (P/B 1.27) and price-to-sales (P/S 6.59) multiples relative to typical specialty-chemicals comparable ranges, even as P/E multiples run elevated given current earnings. The divestiture activity and reiterated guidance frame a clearer earnings base and potential capital return optionality.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2025-06-30
REPORT DATE: 2025-08-05
NEXT REPORT DATE: 2025-11-04
CASH FLOW  Begin Period Cash Flow 650.0 M
 Operating Cash Flow 241.0 M
 Capital Expenditures -95.00 M
 Change In Working Capital -133.00 M
 Dividends Paid -102.00 M
 Cash Flow Delta 166.0 M
 End Period Cash Flow 816.0 M
 
INCOME STATEMENT REVENUE
 Total Revenue 2.8 B
 Forward Revenue 333.5 M
COSTS
 Cost Of Revenue 1.7 B
 Depreciation 97.0 M
 Depreciation and Amortization 242.0 M
 Research and Development 182.0 M
 Total Operating Expenses 2.5 B
PROFITABILITY
 Gross Profit 1.0 B
 EBITDA 837.0 M
 EBIT 595.0 M
 Operating Income 220.0 M
 Interest Income
 Interest Expense 61.0 M
 Net Interest Income -61.00 M
 Income Before Tax 534.0 M
 Tax Provision -78.00 M
 Tax Rate 21.0 %
 Net Income 612.0 M
 Net Income From Continuing Operations 612.0 M
EARNINGS
 EPS Estimate 1.12
 EPS Actual 1.15
 EPS Difference 0.03
 EPS Surprise 2.679 %
 Forward EPS 1.15
 
BALANCE SHEET ASSETS
 Total Assets 26.1 B
 Intangible Assets 14.7 B
 Net Tangible Assets -309.00 M
 Total Current Assets 5.9 B
 Cash and Short-Term Investments 816.0 M
 Cash 816.0 M
 Net Receivables 1.8 B
 Inventory 2.5 B
 Long-Term Investments 258.0 M
LIABILITIES
 Accounts Payable 1.3 B
 Short-Term Debt 500.0 M
 Total Current Liabilities 3.2 B
 Net Debt 5.4 B
 Total Debt 6.8 B
 Total Liabilities 11.7 B
EQUITY
 Total Equity 14.4 B
 Retained Earnings -3.21 B
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 56.20
 Shares Outstanding 256.300 M
 Revenue Per-Share 10.78
VALUATION
 Market Capitalization 18.2 B
 Enterprise Value 24.3 B
 Enterprise Multiple 28.986
Enterprise Multiple QoQ -167.781 %
Enterprise Multiple YoY -39.008 %
Enterprise Multiple IPRWA high: 85.583
median: 85.583
mean: 63.222
IFF: 28.986
low: -118.916
 EV/R 8.778
CAPITAL STRUCTURE
 Asset To Equity 1.813
 Asset To Liability 2.235
 Debt To Capital 0.322
 Debt To Assets 0.262
Debt To Assets QoQ -25.213 %
Debt To Assets YoY 889.585 %
Debt To Assets IPRWA high: 0.733
median: 0.378
mean: 0.35
IFF: 0.262
low: 0.003
 Debt To Equity 0.476
Debt To Equity QoQ -36.772 %
Debt To Equity YoY 765.756 %
Debt To Equity IPRWA high: 2.523
median: 0.962
mean: 0.874
IFF: 0.476
low: 0.003
PRICE-BASED VALUATION
 Price To Book (P/B) 1.265
Price To Book QoQ -16.964 %
Price To Book YoY -24.938 %
Price To Book IPRWA high: 14.757
median: 8.223
mean: 5.733
IFF: 1.265
low: 0.307
 Price To Earnings (P/E) 65.562
Price To Earnings QoQ 0.191 %
Price To Earnings YoY -19.089 %
Price To Earnings IPRWA high: 139.289
median: 139.289
mean: 108.11
IFF: 65.562
low: -3.22
 PE/G Ratio -15.734
 Price To Sales (P/S) 6.595
Price To Sales QoQ -6.638 %
Price To Sales YoY -20.718 %
Price To Sales IPRWA high: 20.44
median: 19.039
mean: 13.699
IFF: 6.595
low: 0.914
FORWARD MULTIPLES
Forward P/E 66.285
Forward PE/G -15.907
Forward P/S 54.652
EFFICIENCY OPERATIONAL
 Operating Leverage 59.186
ASSET & SALES
 Asset Turnover Ratio 0.102
Asset Turnover Ratio QoQ 1.772 %
Asset Turnover Ratio YoY 5.875 %
Asset Turnover Ratio IPRWA high: 0.334
median: 0.175
mean: 0.167
IFF: 0.102
low: 0.003
 Receivables Turnover 1.56
Receivables Turnover Ratio QoQ -7.636 %
Receivables Turnover Ratio YoY 1.317 %
Receivables Turnover Ratio IPRWA high: 2.422
IFF: 1.56
mean: 1.474
median: 1.361
low: 0.117
 Inventory Turnover 0.711
Inventory Turnover Ratio QoQ -8.967 %
Inventory Turnover Ratio YoY -4.992 %
Inventory Turnover Ratio IPRWA high: 2.465
median: 1.426
mean: 1.234
IFF: 0.711
low: 0.034
 Days Sales Outstanding (DSO) 58.484
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 114.152
Cash Conversion Cycle Days QoQ 8.147 %
Cash Conversion Cycle Days YoY 0.13 %
Cash Conversion Cycle Days IPRWA high: 488.171
IFF: 114.152
mean: 91.225
median: 55.264
low: -103.0
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 1.007
 CapEx To Revenue -0.034
 CapEx To Depreciation -0.979
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 20.1 B
 Net Invested Capital 20.6 B
 Invested Capital 20.6 B
 Net Tangible Assets -309.00 M
 Net Working Capital 2.7 B
LIQUIDITY
 Cash Ratio 0.256
 Current Ratio 1.862
Current Ratio QoQ -0.614 %
Current Ratio YoY -21.724 %
Current Ratio IPRWA high: 6.372
mean: 1.988
IFF: 1.862
median: 1.442
low: 0.717
 Quick Ratio 1.076
Quick Ratio QoQ -20.809 %
Quick Ratio YoY -37.053 %
Quick Ratio IPRWA high: 3.851
mean: 1.364
median: 1.122
IFF: 1.076
low: 0.803
COVERAGE & LEVERAGE
 Debt To EBITDA 8.184
 Cost Of Debt 0.575 %
 Interest Coverage Ratio 9.754
Interest Coverage Ratio QoQ -175.032 %
Interest Coverage Ratio YoY 194.112 %
Interest Coverage Ratio IPRWA high: 24.749
IFF: 9.754
median: 9.66
mean: 7.163
low: -45.933
 Operating Cash Flow Ratio 0.216
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 67.453
DIVIDENDS
 Dividend Coverage Ratio 6.0
 Dividend Payout Ratio 0.167
 Dividend Rate 0.40
 Dividend Yield 0.006
PERFORMANCE GROWTH
 Asset Growth Rate -7.585 %
 Revenue Growth -2.779 %
Revenue Growth QoQ -206.967 %
Revenue Growth YoY 705.507 %
Revenue Growth IPRWA high: 47.859 %
mean: 9.628 %
median: 8.936 %
IFF: -2.779 %
low: -4.472 %
 Earnings Growth -4.167 %
Earnings Growth QoQ -117.574 %
Earnings Growth YoY -256.949 %
Earnings Growth IPRWA high: 346.154 %
mean: 30.64 %
median: 26.0 %
IFF: -4.167 %
low: -380.0 %
MARGINS
 Gross Margin 37.265 %
Gross Margin QoQ 2.362 %
Gross Margin YoY 0.803 %
Gross Margin IPRWA high: 62.406 %
median: 44.778 %
mean: 37.747 %
IFF: 37.265 %
low: -24.576 %
 EBIT Margin 21.527 %
EBIT Margin QoQ -166.306 %
EBIT Margin YoY 137.369 %
EBIT Margin IPRWA high: 46.541 %
IFF: 21.527 %
median: 18.287 %
mean: 14.12 %
low: -33.607 %
 Return On Sales (ROS) 7.959 %
Return On Sales QoQ -124.515 %
Return On Sales YoY -12.239 %
Return On Sales IPRWA high: 23.528 %
median: 18.253 %
mean: 14.772 %
IFF: 7.959 %
low: -33.437 %
CASH FLOW
 Free Cash Flow (FCF) 146.0 M
 Free Cash Flow Yield 0.801 %
Free Cash Flow Yield QoQ -409.266 %
Free Cash Flow Yield YoY 24.186 %
Free Cash Flow Yield IPRWA high: 5.667 %
mean: 1.028 %
IFF: 0.801 %
median: 0.633 %
low: -1.464 %
 Free Cash Growth -380.769 %
Free Cash Growth QoQ 204.615 %
Free Cash Growth YoY -58.422 %
Free Cash Growth IPRWA high: 333.766 %
median: 268.897 %
mean: 63.24 %
IFF: -380.769 %
low: -926.923 %
 Free Cash To Net Income 0.239
 Cash Flow Margin 24.928 %
 Cash Flow To Earnings 1.126
VALUE & RETURNS
 Economic Value Added 0.03
 Return On Assets (ROA) 2.251 %
Return On Assets QoQ -162.947 %
Return On Assets YoY 298.407 %
Return On Assets IPRWA high: 11.068 %
median: 2.274 %
IFF: 2.251 %
mean: 1.302 %
low: -18.758 %
 Return On Capital Employed (ROCE) 2.594 %
 Return On Equity (ROE) 0.042
Return On Equity QoQ -154.996 %
Return On Equity YoY 256.161 %
Return On Equity IPRWA high: 0.233
median: 0.056
IFF: 0.042
mean: 0.036
low: -0.393
 DuPont ROE 4.438 %
 Return On Invested Capital (ROIC) 2.283 %
Return On Invested Capital QoQ -192.617 %
Return On Invested Capital YoY -98.962 %
Return On Invested Capital IPRWA high: 4.864 %
median: 3.363 %
mean: 2.486 %
IFF: 2.283 %
low: -11.907 %

Six-Week Outlook

Near-term price action should hinge on confirmation of momentum signals. Technicals show emerging trend strength and momentum indicators that have dipped and begun reversing, implying potential for a rebound toward short-term moving averages if buying volume increases. Negative MRO supports upside toward WMDST’s valuation-implied reference, while RSI and MACD caution that momentum remains fragile until MACD crosses above its signal and price reclaims the 20–50 day averages. Fundamental drivers over the next six weeks include updates on the soy-crush divestiture timing, any incremental capital-return disclosures, and operating cash flow cadence; these could accelerate mean-reversion in price or extend consolidation depending on execution signals and market risk appetite.

About International Flavors & Fragrances Inc.

International Flavors & Fragrances Inc. (NYSE:IFF) creates innovative solutions that enhance consumer experiences through scents, tastes, and nutrition. Headquartered in New York City, IFF operates through four main segments: Nourish, Health & Biosciences, Scent, and Pharma Solutions. The Nourish segment develops natural and plant-based ingredients that enrich flavors in a variety of food and beverage products. Health & Biosciences focuses on producing enzymes, probiotics, and specialty ingredients that support both food and non-food industries, emphasizing health and sustainability. In the Scent division, IFF crafts fragrance compounds, including fine perfumes, consumer fragrances, and essential oils, which enhance personal care and household products. Pharma Solutions delivers innovative cellulosics and seaweed-based excipients for the pharmaceutical industry. Since its founding in 1909, IFF has committed to blending artistry with science, serving a diverse range of markets worldwide. By collaborating with manufacturers in cosmetics, food, beverages, and pharmaceuticals, IFF continues to inspire consumers while advancing industry standards and prioritizing sustainable practices to enhance well-being globally.



© 2025 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.